Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GT Biopharma Appoints New CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

GT Biopharma Appoints New CEO

The new position adds on to his duties of president and chief operating officer

By: Betsy Louda

, Contract Pharma

GT Biopharma announced that Shawn M. Cross will become chairman and chief executive officer effective February 15, 2018.

 

Mr. Cross has held the position of president and chief operating officer of GTBP since November 16, 2017. The plan to add the new positions to his current duties was initiated by the Company’s board of directors to prepare for the company’s next phase of growth. 

 

Mr. Cross will lead GTBP through NASDAQ capital markets listing process, attract institutional investment and analyst coverage to the company, and guide development of its neurology portfolio and its first TriKE into human clinical testing in 2018.

 

He is an internationally recognized healthcare investment banker specializing in the biopharmaceutical sector with over 20 years of experience and has completed dozens of capital markets and strategic transactions for growth-oriented biopharmaceutical companies. Most recently, he was managing director, Head of Biotechnology Investment Banking at Deutsche Bank Securities Inc. 

 

Cross said, “I continue to see a great deal of promise in GT Biopharma’s pipeline of immuno-oncology and neurology therapeutics and am honored to become Chairman and Chief Executive Officer of such a dynamic company. I look forward to announcing additional experienced members to our management team and board in the coming weeks.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters